Chemopreventive effect of Curcuma longa Linn on liver pathology in HBx transgenic mice

Integrative Cancer Therapies

Volumn 10, Issue 2, 2011, Pages 168-177

  Kim, Jungsun ^a   Ha, Hye Lin ^b,c   Moon, Hyung Bae ^d   Lee, Yeon Weol ^a   Cho, Chong Kwan ^a   Yoo, Hwa Seung ^a   Yu, Dae Yeul ^b,c  

^a Daejeon University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c University of Science and Technology (UST)   (South Korea)

^d Wonkwang University   (South Korea)

Author keywords

chemopreventive effect; Curcuma longa Linn (CLL); HBV X protein (HBx); hepatocellular carcinoma; p53

Indexed keywords

CURCUMA LONGA EXTRACT; CYCLINE; HEPATITIS B VIRUS X PROTEIN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CURCUMA LONGA; CURCUMA LONGA LINN; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DYSPLASIA; GENE EXPRESSION; HISTOLOGY; IN VIVO STUDY; INTRAABDOMINAL FAT; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER PROTECTION; LIVER REGENERATION; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHEMOPREVENTION; CURCUMA; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE EXPRESSION; HEPATOCYTES; INTRA-ABDOMINAL FAT; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; ORGAN SIZE; PHOSPHORYLATION; PLANT EXTRACTS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79959809819     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735410380613     Document Type: Article

References (38)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557-2576. (Pubitemid 46890874)
2. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol. 2000;14: 703-709.
3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97-107. (Pubitemid 38365759)
4. Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res. 2007;127:164-176. (Pubitemid 47064411)
5. Chisari FV, Klopchin K, Moriyama T, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell. 1989;59:1145-1156. (Pubitemid 20024625)
6. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature. 1991;351:317-320. (Pubitemid 21896589)
7. Tien Kuo M, Savaraj N. Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers. Mol Carcinog. 2006;45:701-709. (Pubitemid 44406641)
8. Dixit VP, Jain P, Joshi SC. Hypolipidaemic effects of Curcuma longa L and Nardostachys jatamansi, DC in triton-induced hyperlipidaemic rats. Indian J Physiol Pharmacol. 1988;32: 299-304. (Pubitemid 18268802)
9. Luper S. A review of plants used in the treatment of liver disease: part two. Altern Med Rev. 1999;4:178-188.
10. Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol. 1973;25:447-452.
11. Ammon HP, Safayhi H, Mack T, Sabieraj J. Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol. 1993;38:113-119. (Pubitemid 23136055)
12. Abe Y, Hashimoto S, Horie T. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res. 1999;39:41-47.
13. Xu YX, Pindolia KR, Janakiraman N, Noth CJ, Chapman RA, Gautam SC. Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. Exp Hematol. 1997;25: 413-422. (Pubitemid 27226860)
14. Kuttan R, Bhanumathy P, Nirmala K, George MC. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 1985;29:197-202. (Pubitemid 16175818)
15. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23(1A):363-398. (Pubitemid 36361976)
16. Devasena T, Rajasekaran KN, Gunasekaran G, Viswanathan P, Menon VP. Anticarcinogenic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione a curcumin analog on DMH-induced colon cancer model. Pharmacol Res. 2003;47:133-140. (Pubitemid 36263448)
17. Di GH, Li HC, Shen ZZ, Shao ZM. Analysis of antiproliferation of curcumin on human breast cancer cells and its mechanism [in Chinese]. Zhonghua Yi Xue Za Zhi. 2003;83: 1764-1768.
18. Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate. 2001;47:293-303. (Pubitemid 32521749)
19. Azuine MA, Bhide SV. Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer. 1992;17:77-83.
20. Moragoda L, Jaszewski R, Majumdar AP. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res. 2001;21(2A):873-878. (Pubitemid 32494183)
21. Bruck R, Ashkenazi M, Weiss S, et al. Prevention of liver cirrhosis in rats by curcumin. Liver Int. 2007;27:373-383. (Pubitemid 46416629)
22. Kim HJ, Yoo HS, Kim JC, et al. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. J Ethnopharmacol. 2009;124:189-196.
23. Yu DY, Moon HB, Son JK, et al. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol. 1999;31:123-132.
24. Kim KH, Shin HJ, Kim K, et al. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology. 2007;132:1955-1967. (Pubitemid 46677949)
25. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology. 2005;42:5-13. (Pubitemid 40911303)
26. Ohata K, Hamasaki K, Toriyama K, et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer. 2003;97: 3036-3043. (Pubitemid 36676258)
27. Shivji KK, Kenny MK, Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell. 1992;69: 367-374.
28. Essers J, Theil AF, Baldeyron C, et al. Nuclear dynamics of PCNA in DNA replication and repair. Mol Cell Biol. 2005;25:9350-9359. (Pubitemid 41507836)
29. Ori A, Zauberman A, Doitsh G, Paran N, Oren M, Shaul Y. p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53. EMBO J. 1998;17:544-553. (Pubitemid 28045494)
30. Elmore LW, Hancock AR, Chang SF, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci U S A. 1997; 94:14707-14712. (Pubitemid 28041438)
31. Huo TI, Wang XW, Forgues M, et al. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Oncogene. 2001;20:3620-3628. (Pubitemid 32624954)
32. Ogden SK, Lee KC, Barton MC. Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression. J Biol Chem. 2000;275: 27806-27814.
33. Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Cancer Res. 1997;57:5137-5142. (Pubitemid 27498132)
34. Lee SG, Rho HM. Transcriptional repression of the human p53 gene by hepatitis B viral X protein. Oncogene. 2000;19: 468-471. (Pubitemid 30077349)
35. Lin J, Zhu MH, Zhu S, Qu JH, Li FM, Ni CR. The role of hepatitis B virus X gene and p53 on hepatocellular carcinoma cell growth [in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2003;32:43-47.
36. Park SG, Min JY, Chung C, Hsieh A, Jung G. Tumor suppressor protein p53 induces degradation of the oncogenic protein HBx. Cancer Lett. 2009;282:229-237.
37. Matoba S, Kang JG, Patino WD, et al. p53 regulates mitochondrial respiration. Science. 2006;312:1650-1653. (Pubitemid 43902663)
38. Bensaad K, Tsuruta A, Selak MA, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell. 2006; 126:107-120. (Pubitemid 44040989)